Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism

Josef Finsterer (1) , Sinda Zarrouk-Mahjoub (2)

1 Krankenanstalt Rudolfstiftung
2 LR11IPT05 - Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory

Correspondance

Keywords: FGF21; Genotype; Lymphocytes; Mitochondrial; Phenotype; mtDNA

Domains: Life Sciences [q-bio]

Josef Finsterer, Sinda Zarrouk-Mahjoub. Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism. Molecular Genetics and Metabolism Reports, 2018, 14, pp.1-2. ⟨10.1016/j.ymgmr.2017.10.005⟩. ⟨pasteur-02017153⟩